Literature DB >> 20856736

Commentary: do guidelines influence physician practice behavior? The experience with erythropoiesis-stimulating agents.

Marcus Neubauer, Roy A Beveridge, Michael Kolodziej.   

Abstract

Year:  2009        PMID: 20856736      PMCID: PMC2790657          DOI: 10.1200/JOP.091012

Source DB:  PubMed          Journal:  J Oncol Pract        ISSN: 1554-7477            Impact factor:   3.840


× No keyword cloud information.
  3 in total

1.  Patterns of care in community-based oncology practices for anemia associated with myelosuppressive chemotherapy.

Authors:  Arash Naeim; Lyssa Friedman; Kimberly B Whitlock; David J Pasta; Eric P Elkin; Deborah P Lubeck; Hema N Viswanathan; John Glaspy
Journal:  J Oncol Pract       Date:  2009-09       Impact factor: 3.840

2.  Use of epoetin and darbepoetin in patients with cancer: 2007 American Society of Clinical Oncology/American Society of Hematology clinical practice guideline update.

Authors:  J Douglas Rizzo; Mark R Somerfield; Karen L Hagerty; Jerome Seidenfeld; Julia Bohlius; Charles L Bennett; David F Cella; Benjamin Djulbegovic; Matthew J Goode; Ann A Jakubowski; Mark U Rarick; David H Regan; Alan E Lichtin
Journal:  J Clin Oncol       Date:  2007-10-22       Impact factor: 44.544

3.  Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: a meta-analysis of randomised trials.

Authors:  Julia Bohlius; Kurt Schmidlin; Corinne Brillant; Guido Schwarzer; Sven Trelle; Jerome Seidenfeld; Marcel Zwahlen; Michael Clarke; Olaf Weingart; Sabine Kluge; Margaret Piper; Dirk Rades; David P Steensma; Benjamin Djulbegovic; Martin F Fey; Isabelle Ray-Coquard; Mitchell Machtay; Volker Moebus; Gillian Thomas; Michael Untch; Martin Schumacher; Matthias Egger; Andreas Engert
Journal:  Lancet       Date:  2009-05-02       Impact factor: 79.321

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.